Trials / Suspended
SuspendedNCT00979836
Calcium Dobesilate for Chronic Venous Wounds
Randomized, Double-blind Multicenter Clinical Trial Comparing the Efficacy of Calcium Dobesilate With Placebo in the Treatment of Ulcer Secondaries to Chronic Venous Disease
- Status
- Suspended
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 230 (estimated)
- Sponsor
- Fundacion Iberoamericana Itaca · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the efficacy of calcium dobesilate for treating chronic venous wounds. The hypothesis is that venous ulcers treated with standards measures (compressive measures) and calcium dobesilate will heal-up better than venous ulcers treated with standards measures (compressive measures) and placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium Dobesilate | 500 mg/ three times/day for 6 months (capsules) |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2010-07-01
- First posted
- 2009-09-18
- Last updated
- 2011-02-17
Locations
42 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00979836. Inclusion in this directory is not an endorsement.